Spinal Fusion

0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

T-Therapeutics
T-TherapeuticsUK - Cambridge
1 program
Auricular vagus nerve stimulationN/A1 trial
Active Trials
NCT07218133RecruitingEst. Dec 2026
KB
Kuros BiosciencesSwitzerland - Schlieren
1 program
Instrumented posterolateral spinal fusionN/A1 trial
Active Trials
NCT03625544CompletedEst. Oct 2024
SI-BONE
SI-BONESANTA CLARA, CA
1 program
iFuse Bedrock Granite Implant SystemN/A1 trial
Active Trials
NCT05640908Active Not RecruitingEst. Dec 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
T-TherapeuticsAuricular vagus nerve stimulation
SI-BONEiFuse Bedrock Granite Implant System
Kuros BiosciencesInstrumented posterolateral spinal fusion

Clinical Trials (3)

NCT07218133T-TherapeuticsAuricular vagus nerve stimulation

Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

Start: Oct 2025Est. completion: Dec 2026
N/ARecruiting
NCT05640908SI-BONEiFuse Bedrock Granite Implant System

Pelvic Fixation and Fusion During Multilevel Spinal Surgery

Start: Jun 2023Est. completion: Dec 2027
N/AActive Not Recruiting
NCT03625544Kuros BiosciencesInstrumented posterolateral spinal fusion

MagnetOs™ Granules vs. Autograft in Instrumented Posterolateral Spinal Fusion

Start: Jul 2018Est. completion: Oct 2024
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
3 companies competing in this space